Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
- 문서 유형
- 연구출판물 · 리뷰논문
- 등재
- ESCIKCIScopus
- 저널 순위
- JCR Q2Scopus Q2KCI Q2
- 저널
- Blood Research60(1) · 2025
- 피인용
- Scopus 9KCI 1
- FWCI (Scopus)
- 1.44
- JCR IF
- JCR 2024 2.8
- ISSN
- 2287-979X
저자
- Jung, Sung-Hoon제1저자Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea
- Koh, YoungilDivision of Hematology-Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
- Kim, Min KyoungDivision of Hemato-Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea
- Kim, Jin SeokDivision of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea
- Moon, Joon HoDepartment of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
- Min, Chang-KiSeoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- Yoon, Dok HyunDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
- Yoon, Sung-SooDivision of Hematology-Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
- Lee, Je-JungDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea
- Hong, Chae MoonDepartment of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
- Kang, Ka-WonDivision of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea
- Kwon, JihyunDepartment of Internal Medicine, Hematology and Oncology, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea
- Kim, Kyoung HaDivision of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea
- Kim, Dae SikDivision of Oncology & Hematology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea
- Kim, Sung YongHematology & Oncology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea
- Kim, Sung-HyunDivision of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea
- Kim, Yu RiDivision of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea
- Do, Young RokDivision of Hematology-Oncology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea
- Mun, Yeung-ChulDepartment of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea
- Park, Sung-SooSeoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- Park, Young HoonDepartment of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea
- 신호진Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea
- Eom, Hyeon-SeokDepartment of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea
- Yoon, Sang EunDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, Republic of Korea
- Hwang, Sang MeeDepartment of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
- Lee, Won SikDepartment of Internal Medicine, Hematology, Inje University Busan Paik Hospital, Busan, Republic of Korea
- Lee, Myung-WonDivision of Hematology and Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea
- Yi, Jun HoDivision of Hematology-Oncology, Department of Medicine, Chung-Ang University, Seoul, Republic of Korea
- Lee, Ji YunDivision of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
- Lee, Ji HyunDivision of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea
초록
Multiple myeloma (MM), a hematological malignancy, is characterized by malignant plasma cell proliferation in the bone marrow. Recent treatment advances have significantly improved patient outcomes associated with MM. In this study, we aimed to develop comprehensive, evidence-based guidelines for the diagnosis, prognosis, and treatment of MM. We identified 12 key clinical questions essential for MM management, guiding the extensive literature review and meta-analysis of the study. Our guidelines provide evidence-based recommendations by integrating patient preferences with survey data. These recommendations include current and emerging diagnostic tools, therapeutic agents, and treatment strategies. By prioritizing a patient-centered approach and rigorous data analysis, these guidelines were developed to enhance MM management, both in Korea and globally.
키워드
식별자
- Scopus EID
- 2-s2.0-85218474370
- KCI
- ART003211546



로그인
연구물 목록으로